Next Generation Sequencing (NGS) Market Analysis and Growth Prospect 2018 to 2024|Top Companies are Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., QIAGEN, PerkinElmer, Inc., GATC Biotech AG, Agilent Technologies, H

Global Next Generation Sequencing Market Analysis with figures as recent as 2018 and forecasts up to 2024 provides an overview of the industry including its definition, size, share, growth, applications and manufacturing technology. Report also explores the major industry players in detail as well as company profile, product specifications, capacity and production value.

Global Next-Generation Sequencing (NGS) Market accounted to USD 13.51 billion by 2022 growing at a CAGR of 22.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Sample Copy is Available @  http://databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term used to describe a number of different modern sequencing technologies including: These recent technologies allow us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing, and as such have revolutionised the study of genomics and molecular biology.

Illumina (Solexa) sequencing
Roche 454 sequencing
Ion torrent: Proton / PGM sequencing
SOLiD sequencing

Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day. In contrast, the previous Sanger sequencing technology, used to decipher the human genome, required over a decade to deliver the final draft. Although in genome research NGS has mostly superseded conventional Sanger sequencing, it has not yet translated into routine clinical practice. The aim of this article is to review the potential applications of NGS in paediatrics.

The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: 

Illumina, Inc.,
Thermo Fisher Scientific Inc.,
Pacific Biosciences of California, Inc.,
QIAGEN,
BGI,
Oxford Nanopore Technologies,
PerkinElmer, Inc.,
GATC Biotech AG,
Agilent Technologies,
Hoffmann-La Roche Ltd,
Macrogen, Inc.,
Eurofins Scientific,
Biomatters Limited,
Genomatix GmbH,
PierianDx, Myriad Genetics, Inc.,
Partek Incorporated,
DNASTAR, Inc.,
New England Biolabs
Among others.

Global Next Generation Sequencing (NGS) Market By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

To Avail 10% Discount On This Report Mail Us on :-
sopan.gedam@databridgemarketresearch.com

Major Market Drivers and Restraints:

Advanced technology in NGS platforms and increased applications of NGS.
Increased in adoption of NGS among research laboratories and academic institutes.
Efficient speed, cost, and accuracy of the technology.
Drug discovery applications in NGS technology are some of the factors which drives the market.
R&D investments are another factor to grow the market.
Lack of skilled technicians.
Accuracy and uniformity concerns in diagnostics testing limits the growth of market.
Interpretation of complex data and issues regarding storage of sequencing data hinders the market.
Legal and ethical issues are the challenge in the growing market.
Emerging markets are proving the new opportunities in the growth of the market.
Application of NGS in precision medicines & Biomarker discovery.

To Inquire before Buy Complete Report Click here@ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-next-generation-sequencing-ngs-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.